Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000921895-25-002634·683 Capital Management, LLC
Schedule 13G ownership disclosure
REVIVA PHARMACEUTCLS HLDGS I
Common Stock, par value $0.0001 per share · CUSIP: 76152G100
Event date: 2025-09-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- 683 CAPITAL MANAGEMENT, LLC
Shares: 5,435,000.00 · Class: 5.36%
- 683 CAPITAL PARTNERS, LP
Shares: 5,435,000.00 · Class: 5.36%
- Zweiman Ari
Shares: 5,435,000.00 · Class: 5.36%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-002634
- Form type
- SCHEDULE 13G
- Filer
- 683 Capital Management, LLC
- CIK
- CIK 1404574
- Filed
- Sep 29, 2025
- Reporting period
- Sep 22, 2025
- Description
- Schedule 13G beneficial ownership